Investors Enjoying Chinese New Year Celebration

Gene Linn |

Chinese New Year Red EnvelopesChinese New Year on January 23 is a day of lavish spending on celebrations and gifts. Investors in Chinese stocks should feel a bit more comfortable with the extravagances after tidy gains, but they may suffer a spending hangover after trading resumes.

Hong Kong’s benchmark Hang Seng Index rose 167 points, 0.8 percent, Friday to 20,110, a rise of 9.1 percent in 2012. The index of Chinese companies edged 8 points higher, 0.08 percent, to 11,147 Friday, up 12.4 percent for the year to date.

However, even in the auspicious new Year of the Dragon, those gains look shaky.

“We anticipate a tough 1Q12 for China economic growth slowing to 7.5 percent on the back to weakness in 4O11,” CCB International said in an economic analysis on its website.

Guoco Capital said in its Market Watch the Hang Seng is approaching overbought territory. It said, “Leading Chinese banks and Hong Kong property companies, which have been technically overbought, are expected to make a technical correction in near term.”

And then there’s the ever-present danger of yet another piece of scary news about the European debt crisis.

In other words, celebrate while you can. End

DAILY FIX

Hong Kong Blue Chips: +167, +0.8%, to 20,110, 1-20-12, Hang Seng Index

Chinese Stocks in Hong Kong: +8, +0.08 to 11,147, 1-20-12, HSCE Index

Shanghai Stocks: +1.3%, 2,298, 01-20-12, Shanghai Composite Index.

Chinese Stocks in the U.S.: -0.2, 391.3, 01-19-12, Bank of New York Mellon, ADR Index-China

Insight: Hong Blue chips rose above 20,00 on the last day of trading before the break next Monday through Wednesday for Chinese New Years. Local big banks surge after healthy gains by US banks KGI Asia. 1-20-12

Quotable: "The momentum should be able to maintain on the last trading day before CNY (Chinese New Year)
.
Chinese Company to Watch: "Google’s poor 4Q11 result should put pressure on Tencent (TCEHY). Short-term investors should consider taking profit on Tencent and wait for a better entry point at (HK)$160-$170.” Guoco Capital, 1-20-12

Brokerages and analysts cited have disclaimers on their websites emphasizing their statements are for information only. They do not endorse my blog, and I don't endorse them.

For a list of Chinese companies sold in the U.S. and information on each company go to http://www.adrbnymellon.com/dr_country_profile.jsp?country=CN

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
NOMPRCCL Nuveen MO Premium Income Muni Fund n/a n/a n/a 0

Comments

Emerging Growth

InMed Pharmaceuticals Inc.

InMed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.…

Private Markets

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…